Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

QLT discontinues phase III trials of tariquidar in NSCLC

May 15, 2003

Theralux granted orphan drug status for CML

May 15, 2003

Checkpoint kinase inhibitors and their use as adjuvants in DNA-damaging cancer therapy

May 15, 2003

Antitumor dolastatin derivative isolated and tested by Spanish researchers

May 15, 2003

Antitumor and antimetastatic effects of a vitamin E analogue

May 13, 2003

New HER2 kinase inhibitors prepared and tested at Takeda

May 13, 2003

Progen updates development status of PI-88, PI-166

May 13, 2003

Spanish researchers synthesize novel synthetic glycoside with potent antitumor activity

May 13, 2003

Topical 5-FU combined with celecoxib reduces UVB-induced skin tumors in mice

May 13, 2003

Efficacy of a new diphenylchlorin sensitizer for PDT

May 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...